Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AHRQ Outcomes Research Should Focus On Diseases, Not Drugs – PhRMA

Executive Summary

Comparative cost-effectiveness research sponsored by the Agency for Healthcare Research & Quality should focus on treatment options rather than comparing drug classes, the Pharmaceutical Research & Manufacturers of America suggested

You may also be interested in...



Rx Comparative Effectiveness Research Funding In Doubt

Prescription drug comparative effectiveness research funding is not in the fiscal year 2005 HHS approps bill reported out of the House Appropriations Committee July 14

Rx Comparative Effectiveness Research Funding In Doubt

Prescription drug comparative effectiveness research funding is not in the fiscal year 2005 HHS approps bill reported out of the House Appropriations Committee July 14

AHRQ Comparative Study Agenda Should Emphasize Lit Reviews – McClellan

The federal government's investment in comparative effectiveness research for drugs should emphasize literature reviews and other alternatives to clinical trials, Centers for Medicare & Medicaid Services Administrator Mark McClellan said

Related Content

UsernamePublicRestriction

Register

LL1131980

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel